In recent years, various studies have demonstrated that the AST/ALT ratio is used to assess not only liver disease but also cardiovascular disease [22], the surgical prognosis of malignant tumors [23], and the occurrence of venous thromboembolism (VTE) [24]. This evidence concerns the gene GPT and cardiovascular disorder.